Relay Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Equivalents | $84.0M | $124.3M | $143.7M | $151.8M | $280.1M | $447.6M | $42.0M |
| Accounts Receivable | — | — | — | $306.0K | $403.0K | $75.0M | — |
| Inventory | — | — | — | — | — | — | — |
| Total Current Assets | $578.3M | $809.2M | $770.1M | $1.02B | $976.2M | $770.1M | $360.5M |
| Property, Plant & Equipment | $1.7M | $5.9M | $10.9M | $11.6M | $6.5M | $6.3M | $8.1M |
| Goodwill | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | $2.3M | $2.3M | $2.3M | — | — |
| Total Assets | $621.3M | $871.3M | $844.0M | $1.10B | $1.01B | $799.8M | $393.1M |
| Liabilities | |||||||
| Accounts Payable | $7.7M | $14.1M | $9.2M | $10.6M | $8.3M | $6.4M | $7.0M |
| Total Current Liabilities | $25.6M | $50.7M | $30.3M | $63.7M | $24.3M | $13.6M | $12.0M |
| Long-Term Debt | — | — | — | — | — | — | — |
| Total Liabilities | $54.3M | $93.5M | $92.0M | $149.6M | $110.6M | $36.5M | $35.7M |
| Stockholders' Equity | |||||||
| Retained Earnings | $-2.01B | $-1.74B | $-1.40B | $-1.06B | $-768.1M | $-404.2M | $-189.5M |
| Total Stockholders' Equity | $567.1M | $777.8M | $752.0M | $950.2M | $897.8M | $763.3M | $-180.4M |